IDXX
IDEXX Laboratories, Inc.
Stock
$518.39+0.64 (+0.12%)Close Oct 2, 2026
Income statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.6B | $4.3B | $3.9B | $3.7B | $3.4B | $3.2B | $2.7B | $2.4B | $2.2B | $2.0B | $1.8B | $1.6B | $1.5B | $1.4B | $1.3B | $1.2B | $1.1B | $1.0B | $1.0B |
| Cost of revenue | $1.7B | $1.6B | $1.5B | $1.5B | $1.4B | $1.3B | $1.1B | $1.0B | $972M | $872M | $800M | $712M | $670M | $621M | $594M | $572M | $525M | $505M | $494M |
| Gross profit | $2.8B | $2.7B | $2.4B | $2.2B | $2.0B | $1.9B | $1.6B | $1.4B | $1.2B | $1.1B | $975M | $890M | $816M | $756M | $699M | $647M | $579M | $526M | $530M |
| R&D | $261M | $251M | $220M | $191M | $255M | $161M | $141M | $133M | $118M | $109M | $101M | $100M | $98M | $88M | $82M | $76M | $69M | $65M | $71M |
| SG&A | $1.1B | $1.0B | $1.0B | $902M | $851M | $796M | $735M | $680M | $632M | $575M | $524M | $482M | $458M | $401M | $355M | $334M | $306M | $285M | $287M |
| Other operating expenses | — | — | — | — | — | — | — | — | — | — | — | $8.2M | — | — | — | — | — | — | — |
| Operating income | $1.5B | $1.4B | $1.1B | $1.1B | $899M | $932M | $695M | $553M | $491M | $413M | $350M | $300M | $260M | $267M | $263M | $236M | $204M | $176M | $172M |
| Non-operating income | −$34M | −$36M | −$19M | −$36M | −$39M | −$29M | −$33M | −$31M | −$34M | −$32M | −$28M | −$27M | −$14M | −$3.5M | −$1.9M | −$1.8M | −$1.8M | −$1.4M | −$2.3M |
| Pretax income | $1.4B | $1.3B | $1.1B | $1.1B | $860M | $903M | $662M | $522M | $458M | $381M | $322M | $273M | $247M | $263M | $261M | $234M | $202M | $175M | $170M |
| Taxes | $285M | $265M | $222M | $216M | $181M | $158M | $80M | $94M | $81M | $118M | $100M | $81M | $65M | $75M | $82M | $73M | $61M | $52M | $54M |
| Net income | $1.1B | $1.1B | $888M | $845M | $679M | $745M | $582M | $428M | $377M | $263M | $222M | $192M | $182M | $188M | $178M | $162M | $141M | $122M | $116M |
| Diluted EPS | $14.22 | $13.08 | $10.67 | $10.06 | $8.03 | $8.60 | $6.71 | $4.89 | $4.26 | $2.94 | $2.44 | $2.05 | $1.79 | $1.74 | $1.59 | $1.39 | $1.19 | $1.01 | $0.94 |
| Diluted shares | — | 81.0M | 83.2M | 84.0M | 84.6M | 86.6M | 86.7M | 87.5M | 88.5M | 89.6M | 90.9M | 93.6M | 101.5M | 108.0M | 112.3M | 116.4M | 119.1M | 121.4M | 124.5M |
| Revenue growth | — | +10.4% | +6.5% | +8.7% | +4.7% | +18.8% | +12.5% | +8.8% | +12.4% | +10.9% | +10.8% | +7.8% | +7.9% | +6.5% | +6.1% | +10.4% | +7.0% | +0.7% | — |
| Gross margin | 62.4% | 61.8% | 61.0% | 59.8% | 59.5% | 58.8% | 58.0% | 56.7% | 56.1% | 55.7% | 54.9% | 55.6% | 54.9% | 54.9% | 54.1% | 53.0% | 52.4% | 51.0% | 51.7% |
| Operating margin | 32.0% | 31.6% | 29.0% | 30.0% | 26.7% | 29.0% | 25.7% | 23.0% | 22.2% | 21.0% | 19.7% | 18.7% | 17.5% | 19.4% | 20.3% | 19.4% | 18.5% | 17.1% | 16.8% |
| Net margin | 25.0% | 24.6% | 22.8% | 23.1% | 20.2% | 23.2% | 21.5% | 17.8% | 17.0% | 13.4% | 12.5% | 12.0% | 12.2% | 13.6% | 13.8% | 13.3% | 12.8% | 11.8% | 11.3% |